rts logo

Lexicon Pharmaceuticals Inc (LXRX) Analysis & Forecast for 2025

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) is 23.81% higher on its value in year-to-date trading and has touched a low of $0.62 and a high of $3.73 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LXRX stock was last observed hovering at around $0.79 in the last trading session, with the day’s gains setting it 0.12%.

Currently trading at $0.91, the stock is 18.77% and -8.64% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.35 million and changing 15.94% at the moment leaves the stock -43.08% off its SMA200. LXRX registered -39.45% loss for a year compared to 6-month loss of -45.25%. The firm has a 50-day simple moving average (SMA 50) of $1.0214 and a 200-day simple moving average (SMA200) of $1.61145.

The stock witnessed a 33.44% gain in the last 1 month and extending the period to 3 months gives it a -43.21%, and is 18.22% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.65% over the week and 13.81% over the month.

Lexicon Pharmaceuticals Inc (LXRX) has around 285 employees, a market worth around $335.40M and $5.23M in sales. Profit margin for the company is -4109.41%. Distance from 52-week low is 47.37% and -75.49% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.91%).

The EPS is expected to grow by 14.05% this year.

Lexicon Pharmaceuticals Inc (LXRX) Top Institutional Holders

184.0 institutions hold shares in Lexicon Pharmaceuticals Inc (LXRX), with institutional investors hold 82.86% of the company’s shares. The shares outstanding are 361.49M, and float is at 168.72M with Short Float at 18.54%. Institutions hold 81.91% of the Float.

The top institutional shareholder in the company is ARTAL GROUP S.A. with over 175.1 million shares valued at $294.17 million. The investor’s holdings represent 71.3555% of the LXRX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 38.69 million shares valued at $$64.99 million to account for 15.7656 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.89 million shares representing 4.0304% and valued at over $16.62 million, while BRAIDWELL LP holds 3.3803 of the shares totaling 8.29 million with a market value of $13.94 million.

Lexicon Pharmaceuticals Inc (LXRX) Insider Activity

#####

Related Posts